Who is sponsoring NCT02021578?

NCT02021578 is sponsored by Vanderbilt University.

What drugs are being tested in NCT02021578?

Interventions in NCT02021578: Family Cognitive Behavioral Prevention, Written information.

What condition does NCT02021578 study?

NCT02021578 studies Depression.

Is NCT02021578 still recruiting?

NCT02021578 is currently completed. Last updated 1 February 2024.

Last reviewed 2024-02-01 · How we verify

NCT02021578: FDP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Family Depression Prevention Program

Completed NA Last updated 1 February 2024

What this trial tests

NA trial testing Family Cognitive Behavioral Prevention in Depression in 304 participants. Completed in 31 December 2023.

Timeline

1 August 2014

Primary endpoint
30 December 2023

31 December 2023

Quick facts

Lead sponsor	Vanderbilt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	304
Start date	1 August 2014
Primary completion	30 December 2023
Estimated completion	31 December 2023
Sites	2 locations across United States

Drugs / interventions tested

Family Cognitive Behavioral Prevention
Written information

Conditions studied

Depression — all drugs for Depression →

Sponsor

Vanderbilt University

Who can join

Adults 9 to 15, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim is to prevent depression in youth and parents in a single, integrated family intervention. Hypothesis 1a: Children in the Family Depression Prevention (FDP) program will have significantly lower levels of anxious/depressive symptoms and fewer onsets of depressive episodes as compared to children in the Written Information (WI) condition. Hypothesis 1b: In parents, the amount of time in a depressive episode will be significantly lower for those in the FDP program as compared to those in the WI condition.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Executive functioning moderates neural reward processing in youth.
Kryza-Lacombe M, Christian IR, Liuzzi MT, Owen C, et al · · 2021 · cited 8× · PMID 33263153 · DOI 10.3758/s13415-020-00851-z
Racial/ethnic differences in parenting behaviors among depressed parents.
Kado-Walton M, Vreeland A, Henry L, Gruhn M, et al · · 2023 · cited 1× · PMID 37358525 · DOI 10.1037/fam0001125

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Vanderbilt University trials

Trials by the same sponsor.

NCT06598579 — Evaluation of MBCT Implemented in Vietnamese Buddhist Pagoda · NA · not yet recruiting
NCT06482944 — Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes · NA · recruiting
NCT07220746 — Understanding Cognitive-Academic Bidirectionality in Math Learning Disabilities · NA · recruiting
NCT06464497 — Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity · NA · recruiting
NCT05472961 — Eye Movements in Visual Search · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02021578 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University
Last refreshed: 1 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02021578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing